Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Astellas Pharma Inc (OTC Pink - Current Information:ALPMY)

Delayed Data
As of Apr 21
 +0.235 / +1.71%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Astellas Pharma Inc have a median target of 15.37, with a high estimate of 17.57 and a low estimate of 14.10. The median estimate represents a +10.16% increase from the last price of 13.95.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Hold stock in Astellas Pharma Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -63.46%
Growthannually 12.78%


Growthquarterly -12.15%
Growthannually -0.47%
Key to the earnings and sales forecast charts.